FDA Off-Label Reg Changes For Drugs Could Be Driven By Tobacco Policy
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is eliminating ‘intended use’ regulation requiring firms to label products for unintended use when they have knowledge of such use.